Ibnsina Pharma Injects EGP 136 Million into Origin Ventures as of Late March
Ibnsina Pharma announced that it has injected approximately EGP 136 million into the investment firm "Origin Ventures" as of the end of last March.
According to the corporate disclosure, this capital deployment falls within Ibnsina Pharma’s broader investment framework to diversify its financial and strategic operations, leveraging strategic asset backing to tap into high-growth investment portfolios and specialized venture capital streams within the market.